Pyrimidine metabolism was investigated at various stages of somatic embryo
development of white spruce (Picea glauca). The contribution of the de novo
and the salvage pathways of pyrimidine biosynthesis to nucleotide and nucl
eic acid formation and the catabolism of pyrimidine was estimated by the ex
ogenously supplied [6-C-14]erotic acid, an intermediate of the de novo path
way, and with [2-C-14]uridine and [2-C-14]uracil, substrates of the salvage
. pathways. The de novo pathway was very active throughout embryo developme
nt. More than 80% of [6-C-14]orotic acid taken up by the tissue was utilize
d for nucleotide and nucleic acid synthesis in all stages of this process.
The salvage pathways of uridine and uracil were also operative. Relatively
high nucleic acid biosynthesis from uridine was observed, whereas the contr
ibution of uracil salvage to the pyrimidine nucleotide and nucleic acid syn
thesis was extremely limited. A large proportion of uracil was degraded as
(CO2)-C-14, probably via beta -ureidopropionate. Among the enzymes of pyrim
idine metabolism, orotate phosphoribosyltransferase was high during the ini
tial phases of embryo development. after which it gradually declined. Uridi
ne kinase,responsible for the salvage of uridine, showed an opposite patter
n, since its activity increased as embryos developed. Low activities of ura
cil phosphoribosyltransferase and non-specific nucleoside phosphotransferas
e were also detected throughout the developmental period. These results sug
gest that the flux of the de novo and salvage pathways of pyrimidine nucleo
tide biosynthesis in vivo is roughly controlled by the amount of these enzy
mes. However, changing patterns of enzyme activity during embryo developmen
t that were measured in vitro did not exactly correlate with the flux estim
ated by the radioactive precursors. Therefore, other fine control mechanism
s, such as the fluctuation of levels of substrates and/or effecters may als
o participate to the real control of pyrimidine metabolism during white spr
uce somatic embryo development.